| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 38,489 | 43,284 | 54,056 | 60,635 | | Cost of Revenue | 40,917 | 50,289 | 52,467 | 61,137 | | | Gross Profit | (2,428) | (7,005) | 1,589 | (502) | | | Operating Expenses | | Research Development | 5,654 | 6,891 | 8,110 | 11,351 | | Selling General and Administrative | 10,915 | 11,965 | 12,159 | 7,428 | | Non Recurring | 27,000 |
-
| 33,781 | 22,233 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (45,997) | (25,861) | (52,461) | (41,514) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 749 | 2,265 | (788) | 289 | | Earnings Before Interest And Taxes | (45,248) | (23,596) | (53,249) | (41,225) | | Interest Expense | 105 | 143 | 195 |
-
| | Income Before Tax | (45,353) | (23,739) | (53,444) | (41,225) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (45,353) | (23,739) | (53,444) | (41,225) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (45,353) | (23,739) | (53,444) | (41,225) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($45,353) | ($23,739) | ($53,444) | ($41,225) |
|
0.20% Nasdaq 
0.14%
Income Statement
